Literature DB >> 19639393

Prognostic factors and survival of renal clear cell carcinoma patients with bone metastases.

Attila Szendroi1, Elek Dinya, Magdolna Kardos, A Marcel Szász, Zsuzsanna Németh, Katalin Ats, János Kiss, Imre Antal, Imre Romics, Miklós Szendroi.   

Abstract

In our retrospective study the pathological and clinical factors, influencing the survival of 65 renal clear cell carcinoma patients operated for bone metastasis between 1990 and 2008 were examined. Based on Kaplan-Meier curves age, gender, clinical symptoms, pathological fracture, progression to the soft tissues, localization and size of the metastasis, whether the occurrence of multiplex metastases is multiorganic or only located to the skeletal system and the stage and grade of primary renal cancer did not influence the survival. The survival significantly improved if the bone metastases were solitary, low Fuhrman grade, late onset; and radical surgery was performed. Based on Cox regression analysis, survival after bone surgery was influenced by the multiplicity and grade of metastasis and by the radicality of the surgery, whereas survival after nephrectomy was significantly influenced by onset time and grade of metastasis. When the solitary metastasis was radically removed, 75.0% of the patients survived the first, and 35.5% the fifth postoperative year. If the metastasis was multiple or the surgery was not radical, no patient survived the fifth year. This is the first report on the prognostic significance of the Fuhrman grade of bone metastasis of renal cell cancer. While the Fuhrman grade of the primary tumour did not influence the survival, the lower grade of metastasis was associated with a significant longer survival. Therefore in cases of solitary, operable, late onset metastases with low Fuhrman grade radical removal is recommended, since this way in 35.5% of cases 5 year survival can be expected.

Entities:  

Mesh:

Year:  2009        PMID: 19639393     DOI: 10.1007/s12253-009-9184-7

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  20 in total

1.  Metastatic renal cell carcinoma of bone: indications and technique of surgical intervention.

Authors:  Y Kollender; J Bickels; W M Price; K L Kellar; J Chen; O Merimsky; I Meller; M M Malawer
Journal:  J Urol       Date:  2000-11       Impact factor: 7.450

2.  Treatment of osseous metastases in patients with renal cell carcinoma.

Authors:  Sung Taek Jung; Michelle A Ghert; John M Harrelson; Sean P Scully
Journal:  Clin Orthop Relat Res       Date:  2003-04       Impact factor: 4.176

3.  Solitary bony metastasis from renal cell carcinoma: significance of surgical treatment.

Authors:  Bruno Fuchs; Robert T Trousdale; Michael G Rock
Journal:  Clin Orthop Relat Res       Date:  2005-02       Impact factor: 4.176

4.  Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis.

Authors:  H G van der Poel; J A Roukema; S Horenblas; A N van Geel; F M Debruyne
Journal:  Eur Urol       Date:  1999       Impact factor: 20.096

5.  Radical surgery for the solitary bony metastasis from renal-cell carcinoma.

Authors:  K G Baloch; R J Grimer; S R Carter; R M Tillman
Journal:  J Bone Joint Surg Br       Date:  2000-01

6.  Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma.

Authors:  Ken-Ryu Han; Allan J Pantuck; Matthew H T Bui; Oleg Shvarts; Danielo G Freitas; Amnon Zisman; Bradley C Leibovich; Frederick J Dorey; Barbara J Gitlitz; Robert A Figlin; Arie S Belldegrun
Journal:  Urology       Date:  2003-02       Impact factor: 2.649

7.  Survival and prognostic classification of patients with metastatic renal cell carcinoma of bone.

Authors:  Yutaka Toyoda; Nobuo Shinohara; Toru Harabayashi; Takashige Abe; Tomoshige Akino; Ataru Sazawa; Katsuya Nonomura
Journal:  Eur Urol       Date:  2006-11-07       Impact factor: 20.096

8.  Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.

Authors:  Vincenzo Ficarra; Guido Martignoni; Nicola Maffei; Matteo Brunelli; Giacomo Novara; Luisa Zanolla; Maurizio Pea; Walter Artibani
Journal:  Cancer       Date:  2005-01-01       Impact factor: 6.860

Review 9.  Management of distant solitary recurrence in the patient with renal cancer. Contralateral kidney and other sites.

Authors:  J M Kozlowski
Journal:  Urol Clin North Am       Date:  1994-11       Impact factor: 2.241

10.  Osseous metastases secondary to renal cell carcinoma.

Authors:  D A Swanson; W L Orovan; D E Johnson; G Giacco
Journal:  Urology       Date:  1981-12       Impact factor: 2.649

View more
  12 in total

1.  Possible improvement of survival with use of zoledronic acid in patients with bone metastases from renal cell carcinoma.

Authors:  Yosuke Yasuda; Yasuhisa Fujii; Takeshi Yuasa; Shinichi Kitsukawa; Shinji Urakami; Shinya Yamamoto; Junji Yonese; Shunji Takahashi; Iwao Fukui
Journal:  Int J Clin Oncol       Date:  2012-09-11       Impact factor: 3.402

Review 2.  The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.

Authors:  Börje Ljungberg
Journal:  Curr Urol Rep       Date:  2013-02       Impact factor: 3.092

3.  En bloc resection and intercalary prosthesis implantation for the treatment of humeral diaphyseal bone metastases.

Authors:  Feifei Pu; Zhicai Zhang; Baichuan Wang; Jianxiang Liu; Zengwu Shao
Journal:  Int Orthop       Date:  2020-10-06       Impact factor: 3.075

4.  Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey.

Authors:  Daniele Santini; Giuseppe Procopio; Camillo Porta; Toni Ibrahim; Sandro Barni; Calogero Mazzara; Andrea Fontana; Alfredo Berruti; Rossana Berardi; Bruno Vincenzi; Cinzia Ortega; Davide Ottaviani; Giacomo Carteni; Gaetano Lanzetta; Vladimir Virzì; Matteo Santoni; Nicola Silvestris; Maria Antonietta Satolli; Elena Collovà; Antonio Russo; Giuseppe Badalamenti; Stefano Luzi Fedeli; Francesca Maria Tanca; Vincenzo Adamo; Evaristo Maiello; Roberto Sabbatini; Alessandra Felici; Saverio Cinieri; Giuseppe Tonini; Sergio Bracarda
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

5.  Opposite prognostic roles of HIF1α and HIF2α expressions in bone metastatic clear cell renal cell cancer.

Authors:  Attila Szendrői; A Marcell Szász; Magdolna Kardos; Anna-Mária Tőkés; Roni Idan; Miklós Szűcs; Janina Kulka; Péter Nyirády; Miklós Szendrői; Zoltán Szállási; Balázs Győrffy; József Tímár
Journal:  Oncotarget       Date:  2016-07-05

6.  Relationship between LINC00341 expression and cancer prognosis.

Authors:  Meijian Liao; Bing Li; Shikuan Zhang; Qing Liu; Weijie Liao; Weidong Xie; Yaou Zhang
Journal:  Oncotarget       Date:  2017-02-28

7.  Establishment of predictive model for patients with kidney cancer bone metastasis: a study based on SEER database.

Authors:  Kun-Chi Hua; Yong-Cheng Hu
Journal:  Transl Androl Urol       Date:  2020-04

8.  Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study.

Authors:  Keyi Wang; Zonglin Wu; Guangchun Wang; Heng Shi; Jinbo Xie; Lei Yin; Tianyuan Xu; Weipu Mao; Bo Peng
Journal:  Int Braz J Urol       Date:  2021 Mar-Apr       Impact factor: 1.541

Review 9.  Diagnostic algorithm, prognostic factors and surgical treatment of metastatic cancer diseases of the long bones and spine.

Authors:  Miklós Szendrői; Imre Antal; Attila Szendrői; Áron Lazáry; Péter Pál Varga
Journal:  EFORT Open Rev       Date:  2017-09-01

Review 10.  Skeletal metastasis in renal cell carcinoma: A review.

Authors:  Masood Umer; Yasir Mohib; Muhammed Atif; Muhammad Nazim
Journal:  Ann Med Surg (Lond)       Date:  2018-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.